{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:02:34Z","timestamp":1760425354477},"reference-count":22,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"BioCis Pharma Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1002\/nau.22818","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T19:40:10Z","timestamp":1436902810000},"page":"786-791","source":"Crossref","is-referenced-by-count":10,"title":["Intravesical treatment with cis-urocanic acid improves bladder function in rat model of acute bladder inflammation"],"prefix":"10.1002","volume":"35","author":[{"given":"Yvonne","family":"Konkol","sequence":"first","affiliation":[{"name":"Pharmatest Services Ltd.; Turku Finland"},{"name":"Department of Cell Biology and Anatomy; Institute of Biomedicine; University of Turku; Turuk Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni","family":"Bernoulli","sequence":"additional","affiliation":[{"name":"Pharmatest Services Ltd.; Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomi","family":"Streng","sequence":"additional","affiliation":[{"name":"Department of Biology; Laboratory of Animal Physiology and Department of Pharmacology; Drug Development and Therapeutics; University of Turku; Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[{"name":"BioCis Pharma Ltd.; Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Laihia","sequence":"additional","affiliation":[{"name":"BioCis Pharma Ltd.; Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Leino","sequence":"additional","affiliation":[{"name":"BioCis Pharma Ltd.; Turku Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"10.1002\/nau.22818-BIB0001|nau22818-cit-0001","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","article-title":"AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"185","author":"Hanno","year":"2011","journal-title":"J Urol"},{"key":"10.1002\/nau.22818-BIB0002|nau22818-cit-0002","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrurol.2012.217","article-title":"Intravesical treatments of bladder pain syndrome\/interstitial cystitis","volume":"9","author":"Neuhaus","year":"2012","journal-title":"Nat Rev Urol"},{"key":"10.1002\/nau.22818-BIB0003|nau22818-cit-0003","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1464-410X.2009.08611.x","article-title":"Protodynamic therapy for bladder cancer: In vitro results of a novel treatment concept","volume":"104","author":"Laihia","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22818-BIB0004|nau22818-cit-0004","first-page":"1799","article-title":"Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro","volume":"15","author":"Viiri","year":"2009","journal-title":"Mol Vis"},{"key":"10.1002\/nau.22818-BIB0005|nau22818-cit-0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2133.2012.11026.x","article-title":"Topical cis-urocanic acid attenuates oedema and erythema in acute and subacute skin inflammation in the mouse","volume":"167","author":"Laihia","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1002\/nau.22818-BIB0006|nau22818-cit-0006","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.juro.2011.11.080","article-title":"Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder","volume":"187","author":"Arentsen","year":"2012","journal-title":"J Urol"},{"key":"10.1002\/nau.22818-BIB0007|nau22818-cit-0007","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0022-5347(05)67204-7","article-title":"Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction","volume":"164","author":"Pandita","year":"2000","journal-title":"J Urol"},{"key":"10.1002\/nau.22818-BIB0008|nau22818-cit-0008","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-5347(01)69129-8","article-title":"In vivo models of interstitial cystitis","volume":"167","author":"Westropp","year":"2002","journal-title":"J Urol"},{"key":"10.1002\/nau.22818-BIB0009|nau22818-cit-0009","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/iju.12119","article-title":"Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis","volume":"20","author":"Shimizu","year":"2013","journal-title":"Int J Urol"},{"key":"10.1002\/nau.22818-BIB0010|nau22818-cit-0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1464-410X.2007.07044.x","article-title":"Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid","volume":"100","author":"Kirimoto","year":"2007","journal-title":"BJU Int"},{"key":"10.1002\/nau.22818-BIB0011|nau22818-cit-0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2006.03.084","article-title":"The role of the urothelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis","volume":"69","author":"Parsons","year":"2007","journal-title":"Urology"},{"key":"10.1002\/nau.22818-BIB0012|nau22818-cit-0012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/iju.12358","article-title":"Intravesical hyaluronidase causes chronic cystitis in a rat model: A potential model of bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Lv","year":"2014","journal-title":"Int J Urol"},{"key":"10.1002\/nau.22818-BIB0013|nau22818-cit-0013","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1464-410X.2009.08673.x","article-title":"Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity","volume":"104","author":"Tyagi","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22818-BIB0014|nau22818-cit-0014","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1464-410X.2006.06274.x","article-title":"MN-001, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat model","volume":"98","author":"Rajasekaran","year":"2006","journal-title":"BJU Int"},{"key":"10.1002\/nau.22818-BIB0015|nau22818-cit-0015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.urology.2007.07.056","article-title":"Use of sulfated chitosan derivative to reduce bladder inflammation in the rat","volume":"70","author":"Jordan","year":"2007","journal-title":"Urology"},{"key":"10.1002\/nau.22818-BIB0016|nau22818-cit-0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol Toxicol"},{"key":"10.1002\/nau.22818-BIB0017|nau22818-cit-0017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1464-410X.2007.07310.x","article-title":"Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats","volume":"101","author":"Masuda","year":"2008","journal-title":"BJU Int"},{"key":"10.1002\/nau.22818-BIB0018|nau22818-cit-0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/nau.20298","article-title":"Oxidative stress reduces the muscarinic receptor function in the urinary bladder","volume":"26","author":"de Jongh","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22818-BIB0019|nau22818-cit-0019","first-page":"2311","article-title":"Cis-urocanic acid inhibits SAPK\/JNK signaling pathway in UV-B exposed human corneal epithelial cells in vitro","volume":"17","author":"Jauhonen","year":"2011","journal-title":"Mol Vis"},{"key":"10.1002\/nau.22818-BIB0020|nau22818-cit-0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2460\/ajvr.70.3.373","article-title":"Effects of intramammary infusion of cis-urocanic acid on mastitis-associated inflammation and tissue injury in dairy cows","volume":"70","author":"Bannerman","year":"2009","journal-title":"Am J Vet Res"},{"key":"10.1002\/nau.22818-BIB0021|nau22818-cit-0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2340\/00015555-1735","article-title":"Three randomised phase I\/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis","volume":"94","author":"Peltonen","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1002\/nau.22818-BIB0022|nau22818-cit-0022","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.3168\/jds.S0022-0302(06)72464-X","article-title":"Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species","volume":"89","author":"Rinaldi","year":"2006","journal-title":"J Dairy Sci"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22818","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22818","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22818\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T21:00:07Z","timestamp":1625346007000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22818"}},"subtitle":["<i>Cis<\/i>\n-Urocanic Acid for Intravesical Treatment"],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22818","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}